Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Detectable subclinical myocardial necrosis is associated with cardiovascular risk in stable patients with diabetes.

Tang WH, Wu Y, Britt EB Jr, Iqbal N, Hazen SL.

Diabetes Care. 2013 May;36(5):1126-31. doi: 10.2337/dc11-1969. Epub 2013 Feb 7.

2.

Subclinical myocardial necrosis and cardiovascular risk in stable patients undergoing elective cardiac evaluation.

Tang WH, Wu Y, Nicholls SJ, Brennan DM, Pepoy M, Mann S, Pratt A, Van Lente F, Hazen SL.

Arterioscler Thromb Vasc Biol. 2010 Mar;30(3):634-40. doi: 10.1161/ATVBAHA.109.201210. Epub 2009 Dec 23.

3.

Clinical and genetic association of serum ceruloplasmin with cardiovascular risk.

Tang WH, Wu Y, Hartiala J, Fan Y, Stewart AF, Roberts R, McPherson R, Fox PL, Allayee H, Hazen SL.

Arterioscler Thromb Vasc Biol. 2012 Feb;32(2):516-22. doi: 10.1161/ATVBAHA.111.237040. Epub 2011 Nov 10.

4.

Combination of C-reactive protein and cardiac troponin I for predicting adverse cardiac events after sirolimus-eluting stent implantation.

Huang W, Lei H, Liu Q, Ma KH, Qin S, Chang J, Jia FP, He Q, Zuo Z.

Coron Artery Dis. 2009 May;20(3):245-50. doi: 10.1097/MCA.0b013e32832a1950.

PMID:
19387251
5.

Relationship between subclinical cardiac troponin I elevation and culprit lesion characteristics assessed by optical coherence tomography in patients undergoing elective percutaneous coronary intervention.

Lee T, Murai T, Yonetsu T, Suzuki A, Hishikari K, Kanaji Y, Matsuda J, Araki M, Niida T, Isobe M, Kakuta T.

Circ Cardiovasc Interv. 2015 Apr;8(4). pii: e001727. doi: 10.1161/CIRCINTERVENTIONS.114.001727.

6.

[Evaluation of dynamic cardiac troponin I concentrations and C-reactive protein in the monitoring of myocardial infarction in patients with repeated myocardial infarction].

Plak M, Orliński L, Łobos M, Ciesielczyk M, Wlazeł RN, Paradowski MT.

Pol Merkur Lekarski. 2010 Jun;28(168):444-9. Polish.

PMID:
20642101
7.

Association of contemporary sensitive troponin I levels at baseline and change at 1 year with long-term coronary events following myocardial infarction or unstable angina: results from the LIPID Study (Long-Term Intervention With Pravastatin in Ischaemic Disease).

White HD, Tonkin A, Simes J, Stewart R, Mann K, Thompson P, Colquhoun D, West M, Nestel P, Sullivan D, Keech AC, Hunt D, Blankenberg S; LIPID Study Investigators..

J Am Coll Cardiol. 2014 Feb 4;63(4):345-54. doi: 10.1016/j.jacc.2013.08.1643. Epub 2013 Oct 30.

8.

Hemoglobin A1c level and future cardiovascular events among women.

Blake GJ, Pradhan AD, Manson JE, Williams GR, Buring J, Ridker PM, Glynn RJ.

Arch Intern Med. 2004 Apr 12;164(7):757-61.

PMID:
15078645
9.

Optimal cut-off value for cardiac troponin I in ruling out Type 5 myocardial infarction.

Jørgensen PH, Nybo M, Jensen MK, Mortensen PE, Poulsen TS, Diederichsen AC, Mickley H.

Interact Cardiovasc Thorac Surg. 2014 May;18(5):544-50. doi: 10.1093/icvts/ivt558. Epub 2014 Jan 26.

PMID:
24468543
10.

Cardiac troponin I in patients with chronic kidney disease treated conservatively or undergoing long-term haemodialysis.

Flisiński M, Strózecki P, Stefańska A, Zarzycka-Lindner G, Brymora A, Manitius J.

Kardiol Pol. 2007 Sep;65(9):1068-75; discussion 1076-8.

11.

Admission C-reactive protein serum levels and survival in patients with acute myocardial infarction with persistent ST elevation.

Canale ML, Stroppa S, Caravelli P, Petronio AS, Mariotti R, Mariani M, Balbarini A, Barsotti A.

Coron Artery Dis. 2006 Dec;17(8):693-8.

PMID:
17119378
12.

Predictive value of high-sensitivity troponin-I for future adverse cardiovascular outcome in stable patients with type 2 diabetes mellitus.

Yiu KH, Lau KK, Zhao CT, Chan YH, Chen Y, Zhen Z, Wong A, Lau CP, Tse HF.

Cardiovasc Diabetol. 2014 Mar 25;13:63. doi: 10.1186/1475-2840-13-63.

13.

The relationship between plasma osteoprotegerin levels and coronary artery calcification in uncomplicated type 2 diabetic subjects.

Anand DV, Lahiri A, Lim E, Hopkins D, Corder R.

J Am Coll Cardiol. 2006 May 2;47(9):1850-7. Epub 2006 Apr 19.

14.

Prognostic significance of preprocedural troponin-I in patients with non-ST elevation acute coronary syndromes undergoing percutaneous coronary intervention.

Napan S, Kashinath RC, Kadri S, Orig MN, Khadra S.

Coron Artery Dis. 2010 Aug;21(5):261-5. doi: 10.1097/MCA.0b013e32833aa6fa.

PMID:
20555264
16.

Postoperative levels of cardiac troponin versus CK-MB and high-sensitivity C-reactive protein for the prediction of 1-year cardiovascular outcome in patients undergoing vascular surgery.

Kouvelos GN, Milionis HJ, Arnaoutoglou EM, Chasiotis G, Gartzonika C, Papa NK, Tzimas P, Matsagkas MI.

Coron Artery Dis. 2011;22(6):428-34. doi: 10.1097/MCA.0b013e3283487d96.

PMID:
21730823
17.

Glycosylated hemoglobin is associated with decreased endothelial function, high inflammatory response, and adverse clinical outcome in non-diabetic STEMI patients.

Moura FA, Figueiredo VN, Teles BS, Barbosa MA, Pereira LR, Costa AP, Carvalho LS, Cintra RM, Almeida OL, Quinaglia E Silva JC, Nadruz Junior W, Sposito AC; Brasilia Heart Study..

Atherosclerosis. 2015 Nov;243(1):124-30. doi: 10.1016/j.atherosclerosis.2015.09.004. Epub 2015 Sep 8.

PMID:
26385505
18.

Predictive value of perioperative cardiac troponin I for adverse outcome in coronary artery bypass surgery.

Eigel P, van Ingen G, Wagenpfeil S.

Eur J Cardiothorac Surg. 2001 Sep;20(3):544-9.

PMID:
11509277
19.

Diabetes mellitus: subclinical cardiovascular disease and risk of incident cardiovascular disease and all-cause mortality.

Kuller LH, Velentgas P, Barzilay J, Beauchamp NJ, O'Leary DH, Savage PJ.

Arterioscler Thromb Vasc Biol. 2000 Mar;20(3):823-9.

20.

High-sensitivity cardiac troponin I measurement for risk stratification in a stable high-risk population.

Kavsak PA, Xu L, Yusuf S, McQueen MJ.

Clin Chem. 2011 Aug;57(8):1146-53. doi: 10.1373/clinchem.2011.164574. Epub 2011 Jun 23.

Supplemental Content

Support Center